104 related articles for article (PubMed ID: 20453887)
1. Novel alternatively spliced ADAM8 isoforms contribute to the aggressive bone metastatic phenotype of lung cancer.
Hernández I; Moreno JL; Zandueta C; Montuenga L; Lecanda F
Oncogene; 2010 Jul; 29(26):3758-69. PubMed ID: 20453887
[TBL] [Abstract][Full Text] [Related]
2. Tumor-derived interleukin-8 stimulates osteolysis independent of the receptor activator of nuclear factor-kappaB ligand pathway.
Bendre MS; Margulies AG; Walser B; Akel NS; Bhattacharrya S; Skinner RA; Swain F; Ramani V; Mohammad KS; Wessner LL; Martinez A; Guise TA; Chirgwin JM; Gaddy D; Suva LJ
Cancer Res; 2005 Dec; 65(23):11001-9. PubMed ID: 16322249
[TBL] [Abstract][Full Text] [Related]
3. A novel lung cancer signature mediates metastatic bone colonization by a dual mechanism.
Vicent S; Luis-Ravelo D; Antón I; García-Tuñón I; Borrás-Cuesta F; Dotor J; De Las Rivas J; Lecanda F
Cancer Res; 2008 Apr; 68(7):2275-85. PubMed ID: 18381434
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of ADAM9 in non-small cell lung cancer correlates with brain metastasis.
Shintani Y; Higashiyama S; Ohta M; Hirabayashi H; Yamamoto S; Yoshimasu T; Matsuda H; Matsuura N
Cancer Res; 2004 Jun; 64(12):4190-6. PubMed ID: 15205330
[TBL] [Abstract][Full Text] [Related]
5. c-MET mutational analysis in small cell lung cancer: novel juxtamembrane domain mutations regulating cytoskeletal functions.
Ma PC; Kijima T; Maulik G; Fox EA; Sattler M; Griffin JD; Johnson BE; Salgia R
Cancer Res; 2003 Oct; 63(19):6272-81. PubMed ID: 14559814
[TBL] [Abstract][Full Text] [Related]
6. Expression and regulation of a disintegrin and metalloproteinase (ADAM) 8 in experimental asthma.
King NE; Zimmermann N; Pope SM; Fulkerson PC; Nikolaidis NM; Mishra A; Witte DP; Rothenberg ME
Am J Respir Cell Mol Biol; 2004 Sep; 31(3):257-65. PubMed ID: 15087305
[TBL] [Abstract][Full Text] [Related]
7. Voltage-gated sodium channels potentiate the invasive capacities of human non-small-cell lung cancer cell lines.
Roger S; Rollin J; Barascu A; Besson P; Raynal PI; Iochmann S; Lei M; Bougnoux P; Gruel Y; Le Guennec JY
Int J Biochem Cell Biol; 2007; 39(4):774-86. PubMed ID: 17307016
[TBL] [Abstract][Full Text] [Related]
8. Involvement of a disintegrin and a metalloproteinase 8 (ADAM8) in osteoclastogenesis and pathological bone destruction.
Ainola M; Li TF; Mandelin J; Hukkanen M; Choi SJ; Salo J; Konttinen YT
Ann Rheum Dis; 2009 Mar; 68(3):427-34. PubMed ID: 18397961
[TBL] [Abstract][Full Text] [Related]
9. Metalloproteinase disintegrins ADAM8 and ADAM19 are highly regulated in human primary brain tumors and their expression levels and activities are associated with invasiveness.
Wildeboer D; Naus S; Amy Sang QX; Bartsch JW; Pagenstecher A
J Neuropathol Exp Neurol; 2006 May; 65(5):516-27. PubMed ID: 16772875
[TBL] [Abstract][Full Text] [Related]
10. Regulated expression of ADAM8 (a disintegrin and metalloprotease domain 8) in the mouse ovary: evidence for a regulatory role of luteinizing hormone, progesterone receptor, and epidermal growth factor-like growth factors.
Sriraman V; Eichenlaub-Ritter U; Bartsch JW; Rittger A; Mulders SM; Richards JS
Biol Reprod; 2008 Jun; 78(6):1038-48. PubMed ID: 18287572
[TBL] [Abstract][Full Text] [Related]
11. Expression of interleukin 8 and not parathyroid hormone-related protein by human breast cancer cells correlates with bone metastasis in vivo.
Bendre MS; Gaddy-Kurten D; Mon-Foote T; Akel NS; Skinner RA; Nicholas RW; Suva LJ
Cancer Res; 2002 Oct; 62(19):5571-9. PubMed ID: 12359770
[TBL] [Abstract][Full Text] [Related]
12. Androgen deprivation induces selective outgrowth of aggressive hormone-refractory prostate cancer clones expressing distinct cellular and molecular properties not present in parental androgen-dependent cancer cells.
Tso CL; McBride WH; Sun J; Patel B; Tsui KH; Paik SH; Gitlitz B; Caliliw R; van Ophoven A; Wu L; deKernion J; Belldegrun A
Cancer J; 2000; 6(4):220-33. PubMed ID: 11038142
[TBL] [Abstract][Full Text] [Related]
13. Leukocyte common antigen-related tyrosine phosphatase receptor: increased expression and neuronal-type splicing in breast cancer cells and tissue.
Yang T; Zhang JS; Massa SM; Han X; Longo FM
Mol Carcinog; 1999 Jun; 25(2):139-49. PubMed ID: 10365916
[TBL] [Abstract][Full Text] [Related]
14. ADAMs in cancer cell proliferation and progression.
Mochizuki S; Okada Y
Cancer Sci; 2007 May; 98(5):621-8. PubMed ID: 17355265
[TBL] [Abstract][Full Text] [Related]
15. Increased C-CRK proto-oncogene expression is associated with an aggressive phenotype in lung adenocarcinomas.
Miller CT; Chen G; Gharib TG; Wang H; Thomas DG; Misek DE; Giordano TJ; Yee J; Orringer MB; Hanash SM; Beer DG
Oncogene; 2003 Sep; 22(39):7950-7. PubMed ID: 12970743
[TBL] [Abstract][Full Text] [Related]
16. [Molecular mechanism of reversing metastatic phenotype in human high-metastatic large cell lung cancer cell line L9981 by nm23-H1].
Che GW; Zhou QH; Zhu W; Wang YP; Qin Y; Liu LX; Chen XH; Sun YL; Sun ZF
Ai Zheng; 2005 Mar; 24(3):278-84. PubMed ID: 15757527
[TBL] [Abstract][Full Text] [Related]
17. Identification of a novel, functional role for S100A13 in invasive lung cancer cell lines.
Pierce A; Barron N; Linehan R; Ryan E; O'Driscoll L; Daly C; Clynes M
Eur J Cancer; 2008 Jan; 44(1):151-9. PubMed ID: 18061437
[TBL] [Abstract][Full Text] [Related]
18. Expression of heparanase by primary breast tumors promotes bone resorption in the absence of detectable bone metastases.
Kelly T; Suva LJ; Huang Y; Macleod V; Miao HQ; Walker RC; Sanderson RD
Cancer Res; 2005 Jul; 65(13):5778-84. PubMed ID: 15994953
[TBL] [Abstract][Full Text] [Related]
19. Alpha CP-4, encoded by a putative tumor suppressor gene at 3p21, but not its alternative splice variant alpha CP-4a, is underexpressed in lung cancer.
Pio R; Zudaire I; Pino I; Castaño Z; Zabalegui N; Vicent S; Garcia-Amigot F; Odero MD; Lozano MD; Garcia-Foncillas J; Calasanz MJ; Montuenga LM
Cancer Res; 2004 Jun; 64(12):4171-9. PubMed ID: 15205328
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of the LGALS3 (galectin 3) gene in human non-small-cell lung cancer.
Yoshimura A; Gemma A; Hosoya Y; Komaki E; Hosomi Y; Okano T; Takenaka K; Matuda K; Seike M; Uematsu K; Hibino S; Shibuya M; Yamada T; Hirohashi S; Kudoh S
Genes Chromosomes Cancer; 2003 Jun; 37(2):159-64. PubMed ID: 12696064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
